RTTNews | Aug 27, 2020 08:35AM EDT

08:35 Thursday, August 27, 2020 (RTTNews) - OncoSec Begins Phase 2 Study To Evaluate The Combination Of TAVO Plus OPDIVO As Neoadjuvant Therapy For Melanoma

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved